Suppr超能文献

21世纪的淋病——国际及波兰的情况

Gonorrhoea in 21st century--international and Polish situation.

作者信息

Serwin Agnieszka Beata, Koper Marta, Unemo Magnus

出版信息

Przegl Epidemiol. 2014;68(1):39-44, 127-31.

Abstract

Gonorrhoea, according to the latest World Health Organization (WHO) estimates in 2008, is the most frequent bacterial sexually transmitted infection globally, accounting for 106.1 million new cases among adults. Of those cases, 3.4 (3.2%) million were in the WHO European Region. In the European Union and European Economic Area, the incidence of reported cases was 12.6 per 100,000 inhabitants in 2011. The highest incidences were noted in the United Kingdom (37.1), Latvia (24.4) and Ireland (18.6). However, in Poland from 2000 to 2011 the reported incidence declined and was only 0.8-0.9 per 100,000 inhabitants in 2011, that might indicate a suboptimal diagnostics and incomplete case reporting and epidemiological surveillance. A study surveying the diagnostics for gonorrhoea and the case reporting system, including the local and national epidemiological surveillance, in Poland is recommended. The high resistance in Neisseria gonorrhoeae to nearly all antimicrobials introduced for treatment of gonorrhoea is an exceedingly serious problem globally. A few years ago the first extensively-drug resistant N. gonorrhoeae strains with high-level resistance to ceftriaxone, the last remaining option for first-line empirical monotherapy, were reported. Due to this emergent situation, in 2012 the WHO and the European Centre for Disease Prevention and Control (ECDC) launched a global action plan and regional response plan, respectively, to combat the spread of multidrug resistant N. gonorrhoeae. Additionally, an updated European guideline on the diagnosis and treatment of gonorrhoea, recommending treatment with ceftriaxone together with azithromycin, was published in 2012. Worryingly, no antimicrobial susceptibility data for N. gonorrhoeae strains circulating in Poland have been internationally reported in several decades. It is imperative to implement some regular and quality assured antimicrobial susceptibility surveillance for N. gonorrhoeae in Poland and the official Polish treatment guidelines (from 1970s) recommending penicillin G as first-line treatment for gonorrhoea need to be promptly revised.

摘要

根据世界卫生组织(WHO)2008年的最新估计,淋病是全球最常见的细菌性性传播感染,成年人中新增病例达1.061亿例。其中,340万例(占3.2%)发生在世卫组织欧洲区域。在欧盟和欧洲经济区,2011年报告病例的发病率为每10万居民12.6例。发病率最高的是英国(37.1例)、拉脱维亚(24.4例)和爱尔兰(18.6例)。然而,在波兰,2000年至2011年报告的发病率有所下降,2011年仅为每10万居民0.8 - 0.9例,这可能表明诊断不够理想,病例报告和流行病学监测不完整。建议在波兰开展一项关于淋病诊断及病例报告系统的研究,包括地方和国家层面的流行病学监测。淋病奈瑟菌对几乎所有用于治疗淋病的抗菌药物具有高度耐药性,这在全球都是一个极其严重的问题。几年前,首次报告了对头孢曲松(一线经验性单药治疗的最后选择)具有高水平耐药性的广泛耐药淋病奈瑟菌菌株。鉴于这种新出现的情况,2012年世卫组织和欧洲疾病预防控制中心(ECDC)分别启动了一项全球行动计划和区域应对计划,以抗击多重耐药淋病奈瑟菌的传播。此外,2012年发布了一份关于淋病诊断和治疗的更新版欧洲指南,建议使用头孢曲松联合阿奇霉素进行治疗。令人担忧的是,几十年来国际上一直没有关于在波兰传播的淋病奈瑟菌菌株的抗菌药物敏感性数据。必须在波兰对淋病奈瑟菌实施定期且质量有保证的抗菌药物敏感性监测,并且波兰官方的治疗指南(自20世纪70年代起)建议将青霉素G作为淋病的一线治疗药物,需要尽快修订。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验